Tang X, Zhang C, Geng Q, Chen D, Ma W
Virulence. 2025; 16(1):2466503.
PMID: 39954287
PMC: 11834454.
DOI: 10.1080/21505594.2025.2466503.
Artiaga B, Madden D, Kwon T, McDowell C, Keating C, Balaraman V
Vaccines (Basel). 2024; 12(9.
PMID: 39340098
PMC: 11435877.
DOI: 10.3390/vaccines12091068.
Banoun H
Curr Issues Mol Biol. 2024; 46(9):10369-10395.
PMID: 39329969
PMC: 11431526.
DOI: 10.3390/cimb46090617.
Xu S, Yang J
Infect Dis Model. 2024; 9(4):1265-1275.
PMID: 39183947
PMC: 11342263.
DOI: 10.1016/j.idm.2024.07.003.
ODonnell K, Henderson C, Anhalt H, Fusco J, Erasmus J, Lambe T
Int J Mol Sci. 2024; 25(15).
PMID: 39126087
PMC: 11313278.
DOI: 10.3390/ijms25158516.
Enhanced Assessment of Cross-Reactive Antigenic Determinants within the Spike Protein.
Lechuga G, Temerozo J, Napoleao-Pego P, Carvalho J, Gomes L, Bou-Habib D
Int J Mol Sci. 2024; 25(15).
PMID: 39125749
PMC: 11311977.
DOI: 10.3390/ijms25158180.
Non-infectious immune complexes downregulate the production of interferons and tumor necrosis factor-α in primary porcine alveolar macrophages .
Zhang L, Feng X, Chen W, Wang B, He S, Fan H
Front Vet Sci. 2024; 11:1420466.
PMID: 38962699
PMC: 11221350.
DOI: 10.3389/fvets.2024.1420466.
Functional diversification of innate and inflammatory immune responses mediated by antibody fragment crystallizable activities against SARS-CoV-2.
Severa M, Etna M, Andreano E, Ricci D, Cairo G, Fiore S
iScience. 2024; 27(5):109703.
PMID: 38706870
PMC: 11068556.
DOI: 10.1016/j.isci.2024.109703.
The COVID-19 Vaccine in Clinical Trials: Where Are We Now?.
Jiang H, Li J, Zhang P, Huo X, Zhu F
Infect Dis Immun. 2024; 1(1):43-51.
PMID: 38630107
PMC: 8057314.
DOI: 10.1097/ID9.0000000000000003.
Generating prophylactic immunity against arboviruses in vertebrates and invertebrates.
Rawle D, Hugo L, Cox A, Devine G, Suhrbier A
Nat Rev Immunol. 2024; 24(9):621-636.
PMID: 38570719
DOI: 10.1038/s41577-024-01016-6.
The Therapeutic Monoclonal Antibody Bamlanivimab Does Not Enhance SARS-CoV-2 Infection by FcR-Mediated Mechanisms.
Cross R, Wiethoff C, Brown-Augsburger P, Berens S, Blackbourne J, Liu L
Pathogens. 2023; 12(12).
PMID: 38133292
PMC: 10746090.
DOI: 10.3390/pathogens12121408.
Vav proteins do not influence dengue virus replication but are associated with induction of phospho-ERK, IL-6, and viperin mRNA following DENV infection .
Cowell E, Jaber H, Kris L, Fitzgerald M, Sanders V, Norbury A
Microbiol Spectr. 2023; 12(1):e0239123.
PMID: 38054722
PMC: 10782993.
DOI: 10.1128/spectrum.02391-23.
Removal of natural anti-αGal antibodies elicits protective immunity against Gram-negative bacterial infections.
Olivera-Ardid S, Bello-Gil D, Perez-Cruz M, Costa C, Camoez M, Dominguez M
Front Immunol. 2023; 14:1232924.
PMID: 37662909
PMC: 10471972.
DOI: 10.3389/fimmu.2023.1232924.
Antibody-Dependent Enhancement with a Focus on SARS-CoV-2 and Anti-Glycan Antibodies.
Ziganshina M, Shilova N, Khalturina E, Dolgushina N, V Borisevich S, Yarotskaya E
Viruses. 2023; 15(7).
PMID: 37515270
PMC: 10384250.
DOI: 10.3390/v15071584.
A Review: Understanding Molecular Mechanisms of Antibody-Dependent Enhancement in Viral Infections.
Sawant J, Patil A, Kurle S
Vaccines (Basel). 2023; 11(7).
PMID: 37515055
PMC: 10384352.
DOI: 10.3390/vaccines11071240.
Splenic macrophages escalate dengue disease.
Dunagan M, Fox J
Nat Microbiol. 2023; 8(8):1378-1379.
PMID: 37488257
DOI: 10.1038/s41564-023-01437-4.
Uses and Challenges of Antiviral Polyclonal and Monoclonal Antibody Therapies.
Struble E, Rawson J, Stantchev T, Scott D, Shapiro M
Pharmaceutics. 2023; 15(5).
PMID: 37242780
PMC: 10224075.
DOI: 10.3390/pharmaceutics15051538.
Complement Activation by an Anti-Dengue/Zika Antibody with Impaired Fcγ Receptor Binding Provides Strong Efficacy and Abrogates Risk of Antibody-Dependent Enhancement.
Sampei Z, Koo C, Teo F, Toh Y, Fukuzawa T, Gan S
Antibodies (Basel). 2023; 12(2).
PMID: 37218902
PMC: 10204484.
DOI: 10.3390/antib12020036.
Relationship between Vitamin D and Immunity in Older People with COVID-19.
Lauretani F, Salvi M, Zucchini I, Testa C, Cattabiani C, Arisi A
Int J Environ Res Public Health. 2023; 20(8).
PMID: 37107714
PMC: 10138672.
DOI: 10.3390/ijerph20085432.
Combating the challenges of COVID-19 pandemic: Insights into molecular mechanisms, immune responses and therapeutics against SARS-CoV-2.
Negi K, Agarwal M, Pahuja I, Bhardwaj B, Rawat M, Bhaskar A
Oxf Open Immunol. 2023; 4(1):iqad001.
PMID: 37051070
PMC: 9985161.
DOI: 10.1093/oxfimm/iqad001.